IRIS
FALCONI, MASSIMO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 19.685
AS - Asia 18.130
NA - Nord America 12.548
SA - Sud America 4.313
AF - Africa 381
OC - Oceania 30
Continente sconosciuto - Info sul continente non disponibili 12
Totale 55.099
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.948
RU - Federazione Russa 11.727
SG - Singapore 6.916
CN - Cina 5.432
BR - Brasile 3.533
HK - Hong Kong 2.456
IT - Italia 2.011
SE - Svezia 1.881
VN - Vietnam 1.647
FR - Francia 919
DE - Germania 837
GB - Regno Unito 517
IN - India 438
FI - Finlandia 378
RO - Romania 287
AR - Argentina 286
CA - Canada 261
MX - Messico 223
BD - Bangladesh 191
AT - Austria 189
IE - Irlanda 184
NL - Olanda 177
PL - Polonia 163
ZA - Sudafrica 149
JP - Giappone 142
ES - Italia 134
ID - Indonesia 132
EC - Ecuador 131
TR - Turchia 129
IQ - Iraq 128
CO - Colombia 104
UA - Ucraina 74
PK - Pakistan 69
VE - Venezuela 57
PY - Paraguay 56
LT - Lituania 49
MA - Marocco 49
SA - Arabia Saudita 49
CL - Cile 48
UZ - Uzbekistan 48
PH - Filippine 45
PE - Perù 43
NP - Nepal 42
TN - Tunisia 41
UY - Uruguay 35
EG - Egitto 34
KE - Kenya 33
IR - Iran 26
JM - Giamaica 26
BE - Belgio 24
DZ - Algeria 24
IL - Israele 24
MY - Malesia 23
AE - Emirati Arabi Uniti 21
AU - Australia 21
CH - Svizzera 19
JO - Giordania 19
PT - Portogallo 18
TW - Taiwan 17
MD - Moldavia 15
DO - Repubblica Dominicana 14
KZ - Kazakistan 14
LB - Libano 14
BO - Bolivia 13
CR - Costa Rica 13
OM - Oman 13
AZ - Azerbaigian 12
BH - Bahrain 12
HN - Honduras 11
RS - Serbia 11
GR - Grecia 10
AL - Albania 9
GT - Guatemala 9
KR - Corea 9
PA - Panama 9
PS - Palestinian Territory 9
TH - Thailandia 9
BG - Bulgaria 8
TT - Trinidad e Tobago 8
SN - Senegal 7
AO - Angola 6
CI - Costa d'Avorio 6
CZ - Repubblica Ceca 6
EU - Europa 6
GE - Georgia 6
GY - Guiana 6
HU - Ungheria 6
KG - Kirghizistan 6
KW - Kuwait 6
NI - Nicaragua 6
XK - ???statistics.table.value.countryCode.XK??? 6
BA - Bosnia-Erzegovina 5
BY - Bielorussia 5
NZ - Nuova Zelanda 5
PR - Porto Rico 5
QA - Qatar 5
BB - Barbados 4
CY - Cipro 4
ET - Etiopia 4
LY - Libia 4
Totale 55.020
Salva come PNG Salva come JPEG
Città #
Singapore 3.206
Moscow 2.463
Hong Kong 2.424
Dallas 2.225
Ashburn 1.984
San Jose 1.598
Shanghai 1.001
Hefei 881
Lauterbourg 730
Beijing 641
Lawrence 592
Princeton 584
Ho Chi Minh City 572
Milan 548
New York 529
Los Angeles 366
Hanoi 363
São Paulo 346
Nuremberg 222
Boardman 204
Munich 198
Helsinki 191
Dublin 183
Orem 175
Santa Clara 175
London 167
Rome 166
Warsaw 132
Rio de Janeiro 128
Tokyo 117
Chennai 116
Council Bluffs 100
Montreal 99
Washington 98
Turku 96
Denver 94
The Dalles 94
Frankfurt am Main 93
Brooklyn 92
Poplar 91
Pune 91
Lappeenranta 87
Johannesburg 85
Vienna 85
Stockholm 83
Atlanta 81
Belo Horizonte 79
Chicago 79
Guangzhou 79
Phoenix 75
Mexico City 70
Da Nang 69
Seattle 66
Columbus 65
Manchester 63
Brasília 61
Haiphong 61
Cesano Boscone 58
Baghdad 55
Houston 55
Ankara 51
Boston 51
Amsterdam 50
San Francisco 50
Shenzhen 50
Toronto 49
Mumbai 45
Biên Hòa 44
Curitiba 44
Campinas 43
Quito 43
Tianjin 43
Porto Alegre 41
Tashkent 41
Naples 40
Dhaka 39
Guayaquil 38
Guarulhos 37
Hangzhou 36
Salvador 35
Thái Bình 34
St Petersburg 33
Turin 33
Hải Dương 32
Landshut 32
New Delhi 32
Santo André 32
Ribeirão Preto 31
Bologna 29
Cape Town 29
Nairobi 28
Florence 27
Jakarta 27
Brescia 26
Falkenstein 26
Paris 26
Bogotá 25
Buenos Aires 25
Can Tho 25
Caracas 25
Totale 26.978
Salva come PNG Salva come JPEG
Nome #
Recurrence after surgical resection of pancreatic cancer: the importance of postoperative complications beyond tumor biology 353
European Neuroendocrine Tumor Society 2023 guidance paper for functioning pancreatic neuroendocrine tumour syndromes 271
The Brescia International Multidisciplinary Consensus Guidelines on the Optimal Pathology Assessment and Multidisciplinary Pathways of Non-Pancreatic Neoplasms in and Around the Ampulla of Vater (PERIPAN) 177
Defining Biological Borderline Resectable Non-Functioning Pancreatic Neuroendocrine Tumors (NF-PanNETs): A Predictive Model for Preoperative Assessment of Early Recurrence Risk 173
68Ga-DOTATOC PET/MR imaging and radiomic parameters in predicting histopathological prognostic factors in patients with pancreatic neuroendocrine well-differentiated tumours 172
Cellular and transcriptional dynamics of human neutrophils at steady state and upon stress 165
A subset of CD4+CD8α- Cytotoxic T cells is expanded in patients with IgG4-Related type 1 autoimmune pancreatitis and decreases with glucocorticoid treatment 164
European Neuroendocrine Tumor Society (ENETS) 2023 guidance paper for gastroduodenal neuroendocrine tumours (NETs) G1–G3 163
3D Primary Cell Culture: A Novel Preclinical Model For Pancreatic Neuroendocrine Tumors (PanNETs) 161
The 1st i-EUS consensus on the management of pancreatic fluid collections – Part 2 159
A Single-Center Prospective Observational Study Investigating the Accuracy of Preoperative Diagnostic Procedures in the Assessment of Lymph Node Metastases in Nonfunctioning Pancreatic Neuroendocrine Tumors 157
Endoscopic Ultrasound-guided Radiofrequency Ablation Versus Surgical Resection for Treatment of Pancreatic Insulinoma 156
A randomised phase 2 trial of nab-paclitaxel plus gemcitabine with or without capecitabine and cisplatin in locally advanced or borderline resectable pancreatic adenocarcinoma 154
Impact of age, comorbidities and relevant changes on surveillance strategy of intraductal papillary mucinous neoplasms: A competing risk analysis 150
A delphic consensus assessment: Imaging and biomarkers in gastroenteropancreatic neuroendocrine tumor disease management 142
Clinical and economic validation of grade B postoperative pancreatic fistula subclassification 141
(Ir)relevance of Metformin Treatment in Patients with Metastatic Pancreatic Cancer: An Open-Label, Randomized Phase II Trial 141
EUS-guided GastroEnterostomy for management of malignant Gastric Outlet Obstruction: a prospective cohort study with matched comparison with Enteral Stenting 140
Communication, understanding and engagement of patients with pancreatic cancer at time of diagnosis 138
68Ga-DOTA-peptides PET/MRI in pancreatico-duodenal neuroendocrine tumours: a flash pictorial essay on assets and lacks 138
Adjuvant Chemotherapy After Resection of Localized Pancreatic Adenocarcinoma Following Preoperative FOLFIRINOX 136
Autologous Pancreatic Islet Cell Transplantation Following Pancreatectomy for Pancreas Diseases Other Than Chronic Pancreatitis: A 15-Y Study of the Milan Protocol 134
A CD8α− Subset of CD4+SLAMF7+ Cytotoxic T Cells Is Expanded in Patients With IgG4-Related Disease and Decreases Following Glucocorticoid Treatment 134
A tug-of-war in intraductal papillary mucinous neoplasms management: Comparison between 2017 International and 2018 European guidelines 131
A multimodality test to guide the management of patients with a pancreatic cyst 131
Endoscopic ultrasound-guided choledochoduodenostomy versus hepaticogastrostomy combined with gastroenterostomy in malignant double obstruction (CABRIOLET_Pro): A prospective comparative study 130
Association of Upfront Peptide Receptor Radionuclide Therapy With Progression-Free Survival Among Patients With Enteropancreatic Neuroendocrine Tumors 130
A preoperative score to predict early death after pancreatic cancer resection 125
Radiomics in pancreatic neuroendocrine tumors: methodological issues and clinical significance 125
The impact of postoperative complications on recovery of Health-Related Quality of Life and Functional Capacity after pancreatectomy: findings from a prospective observational study 124
A four-step method to centralize pancreatic surgery, accounting for volume, performance and access to care 124
Fat-to-blood recirculation of partially dysfunctional PD-1+CD4 Tconv cells is associated with dysglycemia in human obesity 123
Reliability of grading preoperative pancreatic neuroendocrine tumors on EUS specimens: a systematic review with meta-analysis of aggregate and individual data 122
"Paraduodenal" pancreatitis: results of surgery on 58 consecutives patients from a single institution. 122
Somatostatin receptor activity assessed by 68Ga-DOTATOC PET can preoperatively predict DAXX/ATRX loss of expression in well-differentiated pancreatic neuroendocrine tumors 121
Implications of pregnancy on MCN of the pancreas: A multicentric case-control study 121
Advanced Digestive Neuroendocrine Tumors Metastatic Pattern Is an Independent Factor Affecting Clinical Outcome 121
A polymorphic variant in telomere maintenance is associated with worrisome features and high-risk stigmata development in IPMNs 121
A genome-wide association study identifies eight loci associated with intraductal papillary mucinous neoplasm progression toward malignancy 119
Prognostic value of preoperative CT scan derived body composition measures in resected pancreatic cancer 118
Nab-paclitaxel plus gemcitabine with or without capecitabine and cisplatin in metastatic pancreatic adenocarcinoma (PACT-19): a randomised phase 2 trial 118
Ex-vivo investigation of radiofrequency ablation in pancreatic adenocarcinoma after neoadjuvant chemotherapy 117
"PancPro" as a tool for selecting families eligible for pancreatic cancer screening: An Italian study of incident cases. 117
European evidence-based guidelines on pancreatic cystic neoplasms 116
R Status is a Relevant Prognostic Factor for Recurrence and Survival After Pancreatic Head Resection for Ductal Adenocarcinoma 116
Outcomes of a 3-Year Prospective Surveillance in Individuals at High Risk of Pancreatic Cancer 115
Recent developments in the diagnosis of pancreatic neuroendocrine neoplasms 114
Prediction of the characteristics of aggressiveness of pancreatic neuroendocrine neoplasms (PanNENs) based on CT radiomic features 114
Effect of preoperative biliary stent on postoperative complications after pancreaticoduodenectomy for cancer: Neoadjuvant versus upfront treatment 114
Advantages of laparoscopic distal pancreatectomy: Systematic review and meta-analysis of randomized and matched studies 113
Exploring the optimal therapeutic management of stage ypIA pancreatic ductal adenocarcinoma patients in the era of primary chemotherapy 113
Association of autoimmune pancreatitis and intraductal papillary mucinous neoplasm. A retrospective analysis from a tertiary care referral center 113
Quantitative measurement of 18F-FDG PET/CT uptake reflects the expansion of circulating plasmablasts in IgG4-related disease 113
A Combination of Molecular Markers and Clinical Features Improve the Classification of Pancreatic Cysts. 112
A preoperative clinical risk score including c-reactive protein predicts histological tumor characteristics and patient survival after surgery for sporadic non-functional pancreatic neuroendocrine neoplasms: An international multicenter cohort study 112
A systematic review of surgical resection of liver-only synchronous metastases from pancreatic cancer in the era of multiagent chemotherapy 112
Circulating Neuroendocrine Gene Transcripts (NETest): A Postoperative Strategy for Early Identification of the Efficacy of Radical Surgery for Pancreatic Neuroendocrine Tumors 112
The role of acinar content at pancreatic resection margin in the development of postoperative pancreatic fistula and acute pancreatitis after pancreaticoduodenectomy 112
Preoperative assessment of lymph nodal metastases with [68Ga]Ga-DOTATOC PET radiomics for improved surgical planning in well-differentiated pancreatic neuroendocrine tumours 111
Incidence of endocrine and exocrine insufficiency in patients with autoimmune pancreatitis at diagnosis and after treatment: a systematic review and meta-analysis 110
An alternative splicing signature defines the basal-like phenotype and predicts worse clinical outcome in pancreatic cancer 110
DIAGNOSTIC DELAY AT DIAGNOSIS AND TIME-TO-TREATMENT INFLUENCE OVERALL SURVIVAL OF PANCREATIC CANCER PATIENTS 110
ASO Visual Abstract: The Impact of CT-Assessed Liver Steatosis on Postoperative Complications After Pancreaticoduodenectomy for Cancer 109
ASO Visual Abstract: Very Early Recurrence After Curative Resection for Pancreatic Ductal Adenocarcinoma: Proof of Concept for a "Biologic R2 Definition" 109
Correction to: Prospective minimally invasive pancreatic resections from the IGOMIPS registry: a snapshot of daily practice in Italy on 1191 between 2019 and 2022 (Updates in Surgery, (2023), 75, 6, (1439-1456), 10.1007/s13304-023-01592-7) 108
ASO Visual Abstract: Prognostic Significance and Predictors of Nodal Recurrence After Surgery for Nonfunctioning Pancreatic Neuroendocrine Tumors 108
A Systematic review and meta-analysis on the role of palliative primary resection for pancreatic neuroendocrine neoplasm with liver metastases 108
Quantification of perineural invasion in pancreatic ductal adenocarcinoma: proposal of a severity score system 107
ASO Author Reflections: The Impact of CT-assessed Liver Steatosis on Postoperative Complications after Pancreaticoduodenectomy for Cancer 107
Actual malignancy risk of either operated or non-operated presumed mucinous cystic neoplasms of the pancreas under surveillance 107
A multigenomic liquid biopsy biomarker for neuroendocrine tumor disease outperforms CgA and has surgical and clinical utility 106
The impact of preoperative anemia on pancreatic resection outcomes 106
Active surveillance beyond 5 years is required for presumed branch-duct intraductal papillary mucinous neoplasms undergoing non-operative management 106
B lymphocytes contribute to stromal reaction in pancreatic ductal adenocarcinoma 106
Early biochemical predictors of clinically relevant pancreatic fistula after distal pancreatectomy: a role for serum amylase and C-reactive protein 105
Surveillance of Individuals at High Risk of Developing Pancreatic Cancer: A Prevalence Meta-analysis to Estimate the Rate of Low-yield Surgery 105
Preoperative risk stratification of postoperative pancreatic fistula: A risk-tree predictive model for pancreatoduodenectomy 105
Glucose and lactate levels are lower in EUS-aspirated cyst fluid of mucinous vs non-mucinous pancreatic cystic lesions 105
Association of Smoking with progression from low-risk to high-risk intraductal papillary mucinous neoplasms and pancreatic cancer 104
Minimally invasive spleen-preserving distal pancreatectomy: real-world data from the Italian National Registry of Minimally Invasive Pancreatic Surgery (IGoMIPS) 104
COMMUNI.CARE (COMMUNIcation and Patient Engagement at Diagnosis of PAncreatic CAncer): Study Protocol 104
Anatomically resectable versus biologically borderline resectable pancreatic cancer definition: refining the border beyond anatomical criteria and biological aggressiveness 103
Preoperative predictive factors of laparoscopic distal pancreatectomy difficulty 103
Factors Associated With the Risk of Progression of Low-Risk Branch-Duct Intraductal Papillary Mucinous Neoplasms 103
Diagnosis and treatment in chronic pancreatitis: an international survey and case vignette study 103
La misurazione quantitativa dell’uptake di 18F-FDG in TC/PET riflette l’espansione dei plasmablasti circolanti nella malattia IgG4 correlata 103
B lymphocytes directly contribute to tissue fibrosis in patients with IgG4-related disease. 103
ASO Visual Abstract: Long-Term Survivors After Upfront Resection for Pancreatic Ductal Adenocarcinoma: An Actual 5-Year Analysis of Disease-Specific and Post-Recurrence Survival 102
A Simple Classification of Pancreatic Duct Size and Texture Predicts Postoperative Pancreatic Fistula: A classification of the International Study Group of Pancreatic Surgery 102
Recovery of health-related quality of life after laparoscopic versus open distal pancreatectomy 102
Long-Term Survivors after Upfront Resection for Pancreatic Ductal Adenocarcinoma: An Actual 5-Year Analysis of Disease-Specific and Post-Recurrence Survival 102
Role of pancreatic ductal adenocarcinoma risk factors in intraductal papillary mucinous neoplasm progression 102
Futility of Up-Front Resection for Anatomically Resectable Pancreatic Cancer 102
Preoperative assessment of microvessel density in nonfunctioning pancreatic neuroendocrine tumors (NF-PanNETs) 102
Pathological staging in postneoadjuvant pancreatectomy for pancreatic cancer: implications for adjuvant therapy 101
A multicenter survey on distal pancreatectomy in Italy: results of minimally invasive techniqueand variability of perioperative pathways 101
Time to CA19-9 nadir: a clue for defining optimal treatment duration in patients with resectable pancreatic ductal adenocarcinoma 101
Endoscopic papillectomy for ampullary lesions in patients with familial adenomatous polyposis compared with sporadic lesions: A propensity score-matched cohort 100
Clinical phenotypes of IgG4-related disease reflect different prognostic outcomes 100
Impact of care pathway adherence on recovery following distal pancreatectomy within an enhanced recovery program 100
Totale 12.375
Salva come PNG Salva come JPEG
Categoria #
all - tutte 327.206
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 327.206
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022307 0 2 21 123 31 15 16 9 21 17 9 43
2022/20233.706 1.329 743 218 48 39 397 325 325 167 32 34 49
2023/20242.648 70 132 296 250 249 555 74 268 43 105 189 417
2024/202512.216 1.365 326 326 364 425 1.064 1.795 1.006 2.053 1.594 893 1.005
2025/202636.978 2.730 3.035 2.755 5.243 2.859 1.233 3.613 2.892 10.725 1.893 0 0
Totale 56.069